Abivax (AAVXF) Total Debt (2021 - 2026)

Abivax has reported Total Debt for 6 years, with the latest figure at $405078.0 in Q1 2026.

• On a quarterly basis, Total Debt fell 98.63% year-over-year to $405078.0 in Q1 2026; TTM through Mar 2026 was $405078.0, a 98.63% decrease from a year earlier, with the FY2025 full-year figure at $644880.1, down 83.33% from the prior year.
• Total Debt was $405078.0 for Q1 2026 at Abivax, down from $644880.1 in the prior quarter.
• The five-year high for Total Debt was $81.4 million in Q2 2025, with the low at $405078.0 in Q1 2026.
• Average Total Debt over 5 years is $25.4 million, with a median of $7.5 million recorded in 2022.
• The sharpest annual moves came in 2025 and 2026: Total Debt surged 61.42% in 2025, then tumbled 98.63% in 2026.
• Over 5 years, Total Debt stood at $7.5 million in 2022, then dropped by 2.84% to $7.3 million in 2023, then slumped by 46.9% to $3.9 million in 2024, then plunged by 83.33% to $644880.1 in 2025, then sank by 37.19% to $405078.0 in 2026.
• The last three Total Debt figures came in at $405078.0 (Q1 2026), $644880.1 (Q4 2025), and $47.3 million (Q3 2025), per Business Quant data.